• The aim of this study was to evaluate the risk of cardiovascular disease (CVD) and mortality in patients with diabetes with comorbid depression. (e-dmj.org)
  • However, only few studies have been conducted in a large population to evaluate the risk of CVD and mortality in patients with diabetes and comorbid depression. (e-dmj.org)
  • Aggressive treatment of accompanying serious illness in severe hypoglycemia may help reduce mortality in patients with T2DM. (bvsalud.org)
  • We determined the respective mortality rates with Poisson assumption, and explored the relative risks of all-cause and cardiovascular mortality according to dissimilar levels of hypoglycemia with their achieved mean HbA1c by Cox proportional hazard regression model with adjustment of potential confounders. (bvsalud.org)
  • Association of Coronary Artery Calcium Density and Volume With Predicted Atherosclerotic Cardiovascular Disease Risk and Cardiometabolic Risk Factors in South Asians: The Mediators of Atherosclerosis in South Asians Living in America (MASALA) Study. (stanford.edu)
  • Even though cardiovascular diseases (CVDs) are the main of cause of the global burden of diseases attributable to PM exposure, it remains difficult to show reliable associations between exposure to wildland fire smoke and cardiovascular disease risk in population-based studies. (frontiersin.org)
  • The aim of this study was to ascertain the correlation among disparate levels of hypoglycemia and patients with T2D's achieved mean glycated hemoglobin A1c (HbA1c) with all-cause and cardiovascular mortality. (bvsalud.org)
  • RESULTS: T2D patients with level 3 hypoglycemia had the highest rates of all-cause and cardiovascular mortality. (bvsalud.org)
  • Compared with those who never encountered hypoglycemia, study subjects with level 1 and level 2 hypoglycemia did not show excessive risks of either all-cause or cardiovascular mortality. (bvsalud.org)
  • In T2D patients with hypoglycemia, only those with mean HbA1c ≥9.0% increased all-cause mortality in level 3 hypoglycemia, and cardiovascular mortality in level 1 hypoglycemia. (bvsalud.org)
  • In T2D patients with hypoglycemia, mean HbA1c ≥ 9% increased all-cause or cardiovascular mortality. (bvsalud.org)
  • We also evaluated the association of LDL-C standard deviation (LDL-C-SD) and all-cause and cardiovascular mortality by type of antilipid medication use. (bvsalud.org)
  • Cognitive dysfunction and mood disorders such as depression, anxiety and diabetes-related distress tend to coexist in older people with diabetes and appear to have bidirectional relationship acting as a risk factor and, at the same time, as a consequence of diabetes. (lidsen.com)
  • Healthy lifestyle, appropriate glycaemic control, hypoglycaemia risk reduction and an organised and a holistic care is appropriate. (lidsen.com)
  • Several studies have suggested that depression in patients with diabetes is associated with worse health outcomes, due to poor adherence to treatment regimens [ 9 - 11 ], which leads to poor glycemic control and an increased risk for complications. (e-dmj.org)
  • AIM: In patients with type 2 diabetes (T2D), levels of hypoglycemia and their risk of mortality are not well understood. (bvsalud.org)
  • CONCLUSIONS: Elevated risk of all-cause mortality was exclusively found in patients with level 3 hypoglycemia. (bvsalud.org)
  • Evaluating patient engagement in "KP Connected Pregnancy Care" and its association with utilization, perinatal outcomes and patient satisfaction. (kaiserpermanente.org)
  • Depression is the most common mental health condition in the general population [ 3 ], characterized by sadness, loss of interest or pleasure, feelings of low self-worth, disturbed sleep or appetite, feelings of tiredness, and poor concentration [ 4 ]. (e-dmj.org)
  • Depression has been associated with severe dysglycemia in type 2 diabetes but has not been thoroughly examined specifically in T1D. (kaiserpermanente.org)
  • Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. (medscape.com)
  • Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). (medscape.com)
  • Severe hyperglycemia and hypoglycemia ("severe dysglycemia") are serious complications of type 1 diabetes (T1D). (kaiserpermanente.org)
  • Cox proportional hazards models estimated the associations between depression and severe dysglycemia in both directions, adjusting for demographics, micro- and macrovascular complications, and HbA1c. (kaiserpermanente.org)
  • Although macrovascular and microvascular complications of diabetes are well recognized, there is a lack of awareness regarding other conditions such as cognitive dysfunction, depression, and physical disabilities. (diabetesjournals.org)
  • Diabetes is a chronic metabolic disease characterized by hyperglycemia, the follow-up management of diabetes patients is mostly in the community, but the relationship between key lifestyle indicators in community follow-up and the risk of diabetes is unclear. (bvsalud.org)
  • Cognitive impairments are more prevalent and more severe in diabetics than in nondiabetics. (medscape.com)
  • In addition, patients with cognitive dysfunction can be on a spectrum that extends from a mild cognitive impairment (defined as cognitive dysfunction without difficulty performing daily activities) to severe dysfunction (commonly referred to as dementia). (diabetesjournals.org)
  • Guideline] American Diabetes Association. (medscape.com)
  • Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). (medscape.com)
  • Guideline] American Diabetes Association Professional Practice Committee. (medscape.com)
  • American Diabetes Association clinical practice recommendations: 2013. (medscape.com)